Roche Battered By Biosimilars But Holds On To Initial Forecast

Still Expects CHF4.6bn Impact From Biosimilar Competition For 2021

 
• By Dean Rudge
  
Roche
Roche expects Lucentis competition in 2021 • Source: Shutterstock

More from Biosimilars

More from Products